PXD045908 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use |
Description | Metabolic diseases are closely linked to aberrant synthesis of endogenous fatty acids in the liver, called de novo lipogenesis (DNL), which is mediated by the enzyme fatty acid synthase (FASN). The composition of complex lipids consists of saturated or monosaturated fatty acids, which can be endogenously produced, and polyunsaturated fatty acids (PUFA), which are strictly dietary. Compositional differences between individuals are insufficiently understood and may influence the onset and progression of metabolic and cardiovascular diseases. Here we show that DNL critically determines the use of dietary PUFA. A patient with a hypofunctional heterozygous de novo Arg2177Cys variant in FASN exhibited an elevated composition of PUFA, which was phenocopied by pharmacological inhibition of FASN with TVB-2640 in patients with nonalcoholic steatohepatitis (NASH). In mice, the incorporation rate of supplemented omega-3 PUFA during an obesogenic diet was increased by genetic or pharmacologic reduction of DNL. Mechanistically, we show that the FASN variant exhibited a cysteine-dependent, non-enzymatic acetylation of FASN, which resulted in hyperubiquitinylation and decreased protein stability. Our study further reveals that PUFA storage is an active, enzymatic process controlled by FASN, diacylglycerol O-acyltransferase 2 (DGAT2) and MFSD2A, a membrane-transport protein, and that combining FASN inhibition and PUFA supplementation exerts additive beneficial metabolic effects. These findings provide evidence that the success of PUFA supplementation may depend on the rate of endogenous DNL and that combined PUFA supplementation and FASN inhibition may be a promising approach targeting metabolic disease. |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-22 |
AnnouncementXML | Submission_2024-10-22_06:18:02.895.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Bente Siebels |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | iodoacetamide derivatized residue |
Instrument | Q Exactive; Orbitrap Fusion |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-10-05 02:47:51 | ID requested | |
1 | 2023-12-19 01:10:15 | announced | |
⏵ 2 | 2024-10-22 06:18:03 | announced | 2024-10-22: Updated project metadata. |
Publication List
Keyword List
submitter keyword: diatary polyunsatured fatty acids, fatty acid synthase, me novo lipogenisis,metabolic diseases, LC-MS/MS |
Contact List
Christian Schlein |
contact affiliation | Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Germany |
contact email | c.schlein@uke.de |
lab head | |
Bente Siebels |
contact affiliation | Section for Mass spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf |
contact email | b.siebels@uke.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/12/PXD045908 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD045908
- Label: PRIDE project
- Name: Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use